Milton Park, Oxford, UK

Our Milton Park facility provides fast, flexible early phase development, including pediatric formulation development.  Milton Park is an early phase development facility with strong links to both larger scale development and clinical labeling, packaging, and distribution sites in the Thermo Fisher network.

What we offer:

  • Preclinical, Phase I, and Phase II clinical supplies
  • cGMP Manufacturing
  • Non-GMP suite for accelerated development
  • Full analytical capabilities including stability testing
  • Expertise in tech transfer in close partnership with our Bourgoin, France facility
  • Extensive knowledge of the regulatory landscape

Specialized capabilities include:

  • Pre-formulation
  • Tableting
  • Encapsulation
  • Dry Blending
  • Spray Dry Dispersion, non-GMP
  • Spray granulation
  • Coating
  • API direct filling
  • Roller Compaction
  • Hot Melt Extrusion (HME), non-GMP
  • Pelletization
  • Low & High Shear Wet Granulation and drying
  • • Extrusion / Spheronization
  • Blister packaging – Cold form & Thermoform
  • Cytostatics
  • High Potency (HPAPIs)
  • Solubility enhancement
  • Disposable technologies
  • Over-encapsulation
  • Bottle packaging
  • Sachet filling
  • Quick to Clinic
  • Oral liquid (solutions and suspensions) development
  • Xcelodose

This site features a strong regulatory inspection history from all major international regulatory agencies.

Learn more about the specific equipment and capabilities at this site by downloading our Site Fact Sheet.